You finish the intake, pay, and then… silence. What's actually happening during the 24–96 hours before a tracking number appears? Here's the pipeline, stage by stage — plus what each delay means and when silence stops being normal.
Key Takeaways
- The standard pipeline: intake QA → clinician review → e-prescription → pharmacy verification and compounding queue → cold-chain pack-out → carrier.
- Clinician review is the variable stage: minutes to 48 hours depending on staffing and your state's licensing coverage.
- Pharmacy verification is a real second check — pharmacists can and do bounce prescriptions back with questions.
- Silence past 5 business days without proactive communication is a service failure worth escalating — and remembering at renewal time.
Hour 0–12: Intake Processing
Automated checks run first: state serviceability, identity verification (a legal requirement — the prescriber must know you are who you claim), payment, and flagging of any answers that need human attention before a clinician ever sees the file.
Hour 12–48: The Clinician Review
Your chart lands in a review queue for a clinician licensed in your state. Well-staffed platforms clear queues in hours; platforms with thin coverage in your particular state can take two days — this is the hidden variable behind most "why is it slow" complaints. If the clinician has questions, you'll get a portal message, and the clock pauses until you answer. Check your portal and spam folder on day one — unanswered clarification questions are the most common self-inflicted delay in all of GLP-1 telehealth.
Hour 48–72: E-Prescribing and Pharmacy Verification
Approved prescriptions transmit electronically to the fulfilling pharmacy — for compounded GLP-1s, a state-licensed compounding pharmacy. A pharmacist then runs an independent verification: dose sanity, interactions, prescription validity. This is a genuine safety layer, and occasionally it bounces a script back to the prescriber, adding a day. That bounce is the system working.
Hour 72–96: Compounding Queue and Cold Chain
Your vial is filled from the pharmacy's production schedule, then packed with gel packs in insulated packaging rated for the transit window, and handed to a 1–2-day carrier service. Reputable pharmacies ship early in the week to avoid weekend depot layovers — which is why a Thursday approval often ships Monday, the single most misread "delay" in the process.
When to Actually Worry
| Elapsed time | Status | Read |
|---|---|---|
| 24–72 hrs | In review | Normal |
| 72 hrs–5 days | Approved, no tracking | Normal-ish; compounding queue or weekend hold |
| 5+ business days | No proactive update | Service failure — message support, request a timeline |
| Any point | Clarification question sitting unanswered | The delay is on your side of the net — answer it |
Programs With Clean Pipelines
Speed through this pipeline is a proxy for operational competence. Programs we track with consistently fast intake-to-ship performance:
Embody
Injectable semaglutide — $149 first month
Physician-supervised injectable semaglutide with fast async intake and flat pricing after month one.
Compounded medications are not FDA-approved.
Visit Embody Paid linkRxSpan MD
Telehealth GLP-1 program
Newer telehealth entrant with licensed-provider review and pharmacy fulfillment.
Compounded medications are not FDA-approved.
Visit RxSpan MD Paid linkCare Bare Rx
Injectable + oral options in intake
Fast intake with both injectable and oral compounded pathways.
Compounded medications are not FDA-approved.
Visit Care Bare Rx Paid linkOne more habit: screenshot your intake confirmation and note the date. If you ever need to escalate, "day six, no update, here's my timeline" gets action that vague frustration doesn't.
Affiliate disclosure: Links marked "Paid link" are affiliate links. We may earn a commission if you sign up through them, at no extra cost to you. This supports our independent research.
Compounded medication notice: Compounded medications are not FDA-approved. The FDA does not verify the safety, effectiveness, or quality of compounded drugs before they are marketed. Brand-name alternatives (Wegovy, Ozempic, Zepbound, Rybelsus) are FDA-approved.
Medical disclaimer: This article is for informational purposes only and is not medical advice. GLP-1 medications are prescription drugs. Always consult a licensed healthcare provider about diagnosis, treatment, dosing, and whether these medications are appropriate for you.